FDA Approves Bristol-Myers Squibb's (BMY) New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
Tweet Send to a Friend
(Updated - February 5, 2021 3:06 PM EST)Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
